- Senior Investigator, Section for Translational Research on Retinal and Macular Degeneration
Paul Sieving received his M.D. from the University of Illinois in 1978 and trained in ophthalmology at that institution between 1978 and 1982. He earned a Ph.D. in bioengineering from the University of Illinois in 1981. He was a faculty member at the University of Michigan Medical School for 17 years and moved to NIH in 2001. He combines laboratory research with clinical patient studies of genetic retinal neurodegenerative diseases. He is a member of the Institute of Medicine and currently serves as director of the National Eye Institute.
- (2018). 3-D retina organoids: Building platforms for therapies of the future. Cell Medicine. 10,
- (2018). Accessory heterozygous mutations in cone photoreceptor CNGA3 exacerbate CNG channel-associated retinopathy. JOURNAL OF CLINICAL INVESTIGATION. 128(12), 5663-5675.
- (2018). Analysis of Anatomic and Functional Measures in X-Linked Retinoschisis. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 59(7), 2841-2847.
- (2018). IFT88 mutations identified in individuals with non-syndromic recessive retinal degeneration result in abnormal ciliogenesis. HUMAN GENETICS. 137(6-7), 447-458.
- (2018). Identification of Novel Deletions as the Underlying Cause of Retinal Degeneration in Two Pedigrees. Advances in Experimental Medicine and Biology. 1074, 229-236.